Stock 688222 HITGEN INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases HitGen Inc.

Equities

688222

CNE1000040G3

End-of-day quote Shanghai S.E.
Other stock markets
 06:00:00 2024-06-06 pm EDT 		5-day change 1st Jan Change
11.62 CNY +2.38% Intraday chart for HitGen Inc. -5.99% -22.48%
Apr. 24 HitGen Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Feb. 23 HitGen Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Chengdu HitGen and the Structural Genomics Consortium have reached A Cooperation in the research and development of new drugs based on DEL technology Release time, 2023-09-28
AQ
Pierre Fabre Laboratories and Vernalis announce a drug discovery collaboration in oncology
AQ
Chengdu Hittech and Nested Therapeutics signed a new drug research and development service contract based on DEL technology
AQ
Vernalis Research, a fully owned subsidiary of HitGen Inc., and Unison Medicines Inc. announce a research collaboration in the field of anti-infectives
AQ
Mitsubishi Tanabe Pharma Corporation - Progress of Innovative Drug Discovery Research Collaboration with HitGen
AQ
HitGen and Cambridge Molecular announce a strategic partnership, bringing together DNA-Encoded Libraries and Deep Learning
BU
Vernalis Research - a Fully Owned Subsidiary of HitGen Inc - and Hannibal Innovation Announce the Creation of Dania Therapeutics ApS
BU
HitGen : Vernalis a fully owned subsidiary of HitGen Inc and Servier achieve a milestone in their oncology drug discovery collaboration
AQ
HitGen : Vernalis, a fully owned subsidiary of HitGen Inc., and Servier achieve two milestones in their oncology drug discovery collaboration
AQ
HitGen : Dorian and HitGen Announce Research Collaboration Focused on DNA-Encoded Library Based Drug Discovery
BU
HitGen : and BioAge Announce Research Progress in DNA-Encoded Library Based Drug Discovery Research Collaboration
BU
HitGen : Lipigon Expands Collaboration With HitGen by Selecting Second Target
BU
HitGen : and UPPTHERA Enter Into Drug Discovery Research Collaboration
BU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 688222 Stock
  4. News HitGen Inc.
  5. Press Releases